Peripheral GLP-1 gastroprotection against ethanol: The role of exendin, NO, CGRP, prostaglandins and blood flow

Regulatory Peptides

Volumn 152, Issue 1-3, 2009, Pages 22-27

  Isbil Buyukcoskun, Naciye ^a   Gulec, Guldal ^a   Cam Etoz, Betul ^a   Ozluk, Kasim ^a  

^a ULUDAG UNIVERSITY   (Turkey)

Author keywords

CGRP (8 37); Exendin (9 39); Gastric mucosal blood flow; Gastric mucosal damage; Glucagon like peptide 1; Indomethacin; l NAME

Indexed keywords

ALCOHOL; CALCITONIN GENE RELATED PEPTIDE[8-37]; EXENDIN 4; EXENDIN[9-39]; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROSTAGLANDIN DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STOMACH BLOOD FLOW; STOMACH MUCOSA LESION; STOMACH PROTECTION;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; ETHANOL; GASTRIC MUCOSA; GLUCAGON-LIKE PEPTIDE 1; INDOMETHACIN; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PEPTIDE FRAGMENTS; PROSTAGLANDINS; RATS; RATS, SPRAGUE-DAWLEY; REGIONAL BLOOD FLOW;

RATTUS;

EID: 57249097116     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2008.09.006     Document Type: Article

References (47)

1. Bell G.I., Sanchez-Pescador R., Laybourn P.J., and Najarian R.C. Exon duplication and divergence in the human preproglucagon gene. Nature 304 (1983) 368-371
2. Kieffer T.J., and Habener J.F. The glucagon-like peptides. Endocrine Rev 20 6 (1999) 876-913
3. Holst J.J. Enteroglucagon. Annu Rev Physiol 59 (1997) 257-271
4. Richter G., Feddersen O., Wagner U., Barth P., Göke R., and Göke B. GLP-1 stimulates secretion of macromolecules from airways and relaxes pulmonary artery. Am J Physiol 265 (1993) L374-L381
5. Golpon H.A., Puechner A., Welte T., Wichert P.V., and Feddersen C.O. Vasorelaxant effect of glucagon-like peptide-(7-36) amide and amylin on the pulmonary circulation of the rat. Regul Pept 102 (2001) 81-86
6. Barragan J.M., Eng J., Rodriguez R., and Blazquez E. Neural contribution to the effect of glucagon-like peptide-1-(7-36) amide on arterial blood pressure in rats. Am J Physiol 277 40 (1999) E784-791
7. Isbil-Buyukcoskun N., and Gulec G. Effects of intracerebroventricularly injected glucagon-like peptide-1 on cardiovascular parameters; role of central cholinergic system and vasopressin. Regul Pept 118 (2004) 33-38
8. Buteau J., Roduit R., Susini S., and Prentki M. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells. Diabetologia 42 (1999) 856-864
9. Bose A.K., Mocanu M.M., Carr R.D., Brand C.L., and Yellon D.M. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. Diabetes 54 (2005) 146-151
10. Buteau J., Foisy S., Joly E., and Prentki M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes 52 (2003) 124-132
11. List J.F., He H., and Habener J.F. Glucagon-like peptide-1 receptor and proglucagon expression in mouse skin. Regul Pept 134 (2006) 149-157
12. Nyström T., Gonon A.T., Sjöholm A., and Pernow J. Glucagon-like peptide-1 relaxes rat conduit arteries via an endothelium-independent mechanism. Regul Pept 125 (2005) 173-177
13. Tang-Christensen M., Larsen P.J., Göke R., Fink-Jensen A., Jessop D.S., Moller M., and Sheikh S.P. Central administration of GLP-1 (7-36)amide inhibits food and water intake in rats. Am J Physiol 271 (1996) R848-R856
14. Shousha S., Nakahara K., Nasu T., Sakamoto T., and Murakami N. Effect of glucagon-like peptide-1 and -2 on regulation of food intake, body temperature and locomotor activity in the Japanese quail. Neurosci Lett 415 2 (2007) 102-107
15. Tang-Christensen M., Göke R., Moller M., and Sheikh S.P. GLP-1 and its receptors in the central nervous system are powerful regulators of autonomic functions in the brain. Soc Neurosci Abstr 24 (1994) 561-565
16. Bullock B.P., Heller R.S., and Habener J.F. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology 137 (1996) 2968-2978
17. Larsen P.J., Tang-Christensen M., Holst J.J., and Orskov C. Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem. Neuroscience 77 (1997) 257-270
18. Göke R., Larsen P.J., Mikkelsen J.D., and Sheikh S.P. Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites. Eur J Neurosci 7 (1995) 2294-2300
19. Eng J., Kleiman W.A., Singh L., Singh G., and Raufman J.P. Isolation and characterization of exendin-4, and exendin-3 analogue, from Heloderma suspectum venomFurther evidence for an exendin receptor on dispersed acini from guinea pig pancreas. J Biol Chem 267 (1992) 7402-7405
20. Barragan J.M., Rodriguez R.E., Eng J., and Blazquez E. Interaction of exendin-(9-39) with the effects of glucagon-like peptide-1-(7-36) amide and of exendin-4 on arterial blood pressure and heart rate in rats. Regul Pept 67 (1996) 63-68
21. Kawano S., and Tsuji S. Role of mucosal blood flow: a conceptional review in gastric mucosal injury and protection. J Gastroenterol Hepatol 15 Suppl (2000) D1-D6
22. Guth P.H., Paulsen G., and Nagata H. Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: effect of prostaglandin cytoprotection. Gastroenterology 87 (1984) 1083-1090
23. Isbil-Buyukcoskun N., and Gulec G. Effects of centrally injected GLP-1 in various experimental models of gastric mucosal damage. Peptides 25 (2004) 1179-1183
24. Isbil-Buyukcoskun N., and Gulec G. Investigation of the mechanisms involved in the central effects of glucagon-like peptide-1 on ethanol-induced gastric mucosal lesions. Regul Pept 128 (2005) 57-62
25. Isbil-Buyukcoskun N., Gulec G., and Ozluk K. Protective effect of centrally-injected glucagon-like peptide-1 on reserpine-induced gastric mucosal lesions in rat: possible mechanisms. Turk J Gastroenterol 17 1 (2006) 1-6
26. Isbil-Buyukcoskun N., Gulec G., Cam-Etoz B., and Ozluk K. Central effects of glucagon-like peptide-1 on cold-restraint stress-induced gastric mucosal lesions. Turk J Gastroenterol 3 (2007) 150-156
27. Mersereau W.A., and Hinchey E.J. Effect of gastric acidity on gastric ulceration induced by hemorrhage in the rat, utilizing a gastric chamber technique. Gastroenterology 64 (1973) 1130-1135
28. Imeryuz N., Yeǧen B.C., Bozkurt A., Coskun T., Villanueva-Penacarrillo M.L., and Ulusoy N.B. Glucagon-like peptide-1 inhibits gastric emptying via vagal afferent-mediated central mechanisms. Am J Physiol 273 4 (1997) G920-G927
29. Clementi G., Amico-Roxas M., Caruso A., Cutuli V.M.C., Maugeri S., and Prato A. Protective effects of calcitonin gene-related peptide in different experimental models of gastric ulcers. Eur J Pharmacol 238 (1993) 101-104
30. Guidobono F., Pagani F., Ticozzi C., Sibilia V., Pecile A., and Netti C. Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats. Br J Pharmacol 120 (1997) 581-586
31. Sibilia V., Rindi G., Pagani F., Rapetti D., Locatelli V., Torsello A., Campanini N., Deghenghi R., and Netti C. Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action. Endocrinology 144 1 (2003) 353-359
32. Zueco J.A., Esquifino A.I., Chowen J.A., Alvarez E., Castrillon P.O., and Blazquez E. Coexpression of glucagon-like peptide-1 (GLP-1) receptor, vasopressin, and oxytocin mRNAsin neurons of the rat hypothalamic supraoptic and paraventricular nuclei: effect of GLP-1 (7-36) amide on vasopressin and oxytocin release. J Neurochem 72 1 (1999) 10-16
33. Matsuda H., Li Y., and Yoshikawa M. Gastroprotections of escins Ia, Ib, IIa, and IIb on ethanol-induced gastric mucosal lesions in rats. Eur J Pharmacol 373 1 (1999) 63-70
34. Hui H., Farilla L., Merkel P., and Perfetti R. The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects. Eur J Endocrinol 146 (2002) 863-869
35. Eissele R., Koop H., and Arnold R. Effect of glucagon-like peptide-1 on gastric somatostatin and gastrin secretion in the rat. Scand J Gastroenterol 25 (1990) 449-454
36. Eissele R., Bothe-Sandfort E., Göke B., Eng J., Arnold R., and Koop H. Rat gastric somatostatin and gastrin release: interaction of exendin-4 and truncated glucagon-like peptide-1 (GLP-1) amide. Life Sci 55 (1994) 629-634
37. Giralt M., and Vergara P. Sympathetic pathways mediate GLP-1 actions in the gastrointestinal tract of the rat. Regul Pept 74 (1998) 19-25
38. Wettergren A., Wqjdemann M., and Holst J.J. Glucagon-like peptide-1 inhibits gastropancreatic function by inhibiting central parasympathetic outlow. Am J Physiol 275 38 (1998) 984-992
39. Holzer P., and Guth P.H. Neuropeptide control of rat gastric mucosal blood flow: increase by calcitonin gene-related peptide and vasoactive intestinal polypeptide, but not substance P and neurokinin. Circ Res 12 (1991) 25-31
40. Guidobono F., Pagani F., Sibilia V., Soglian A., Rapetti D., and Netti C. The role of sensory neurons in the antiulcer effect of centrally injected amylin in rat. Peptides 21 (2000) 1537-1541
41. Sternini C., Reeve J.R., and Brecha N. Distribution and characterization of calcitonin gene-related peptide immunoreactivity in the digestive system of normal and capsaicin-treated rats. Gastroenterology 93 (1987) 852-862
42. Sternini C. Enteric and visceral afferent CGRP neurons. Targets of innervation and differential expression patterns. Am NY Acad Sci 657 (1992) 170-186
43. Peskar B.M. Neural aspects of prostaglandin involvement in gastric mucosal defense. J Physiol Pharmacol 52 (2001) 555-568
44. Pawlik M., Ptak A., Pajdo R., Brzozowski T., and Konturek S.J. Sensory nerves and calcitonin gene related peptide in the effect of ischemic preconditioning on acute and chronic gastric lesions induced by ischemia-reperfusion. J Physiol Pharmacol 52 (2001) 569-581
45. Gustaw P., Pawlik W.W., Czarnobilski K., Sendur R., and Konturek S.J. Nitric oxide is involved in the mediation of gastric blood flow and tissue oxygenation. J Physiol Pharmacol 45 (1994) 361-368
46. Whittle B.J.R., Lopez-Bolmonte J., and Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interaction with prostanoids and sensory neuropeptides in the rat. Br J Pharmacol 99 (1990) 607-611
47. Basu A., Charkoudian N., Schrage W., Rizza R.A., Basu R., and Joyner M.J. Beneficial effects of GLP-1 on endothelial function in humans: dampening by glyburide but not by glimepiride. Am J Physiol Endocrinol Metab 293 5 (2007) E1289-E1295